US Bancorp’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429K | Sell |
|
|||||
|
2025
Q1 | $427K | Buy |
|
|||||
|
2024
Q4 | $81.2K | Buy |
|
|||||
|
2024
Q3 | $66.1K | Buy |
|
|||||
|
2024
Q2 | $54.6K | Sell |
|
|||||
|
2024
Q1 | $48.2K | Buy |
|
|||||
|
2023
Q4 | $43.7K | Buy |
|
|||||
|
2023
Q3 | $4.85K | Sell |
|
|||||
|
2023
Q2 | $19.8K | Sell |
|
|||||
|
2023
Q1 | $20.7K | Buy |
|
|||||
|
2022
Q4 | $2.4K | Sell |
|
|||||
|
2022
Q3 | $5K | Sell |
|
|||||
|
2022
Q2 | $6K | Sell |
|
|||||
|
2022
Q1 | $8K | Sell |
|
|||||
|
2021
Q4 | $48K | Buy |
|
|||||
|
2021
Q3 | $38K | Sell |
|
|||||
|
2021
Q2 | $114K | Sell |
|
|||||
|
2021
Q1 | $140K | Buy |
|
|||||
|
2020
Q4 | $32K | Sell |
|
|||||
|
2020
Q3 | $120K | Sell |
|
|||||
|
2020
Q2 | $146K | Sell |
|
|||||
|
2020
Q1 | $139K | Sell |
|
|||||
|
2019
Q4 | $206K | Sell |
|
|||||
|
2019
Q3 | $225K | Sell |
|
|||||
|
2019
Q2 | $367K | Sell |
|
|||||
|
2019
Q1 | $433K | Sell |
|
|||||
|
2018
Q4 | $1.35M | Buy |
|
|||||
|
2018
Q3 | $2.15M | Sell |
|
|||||
|
2018
Q2 | $2.31M | Buy |
|
|||||
|
2018
Q1 | $1.69M | Sell |
|
|||||
|
2017
Q4 | $1.5M | Buy |
|
|||||
|
2017
Q3 | $1.16M | Buy |
|
|||||
|
2017
Q2 | $503K | Buy |
|
|||||
|
2017
Q1 | $407K | Buy |
|
|||||
|
2016
Q4 | $384K | Buy |
|
|||||
|
2016
Q3 | $287K | Buy |
|
|||||
|
2016
Q2 | $168K | Buy |
|
|||||
|
2016
Q1 | $87K | Buy |
|
|||||
|
2015
Q4 | $87K | Buy |
|
|||||
|
2015
Q3 | $55K | Buy |
|
|||||
|
2015
Q2 | $59K | Buy |
|
|||||
|
2015
Q1 | $40K | Sell |
|
|||||
|
2014
Q4 | $34K | Sell |
|
|||||
|
2014
Q3 | $73K | Sell |
|
|||||
|
2014
Q2 | $297K | Sell |
|
|||||
|
2014
Q1 | $348K | Buy |
|
|||||
|
2013
Q4 | $206K | Buy |
|
|||||
|
2013
Q3 | $45K | Buy |
|